Transparent Cap-assisted SpyGlass for Biliary Stricture

Status Recruiting

Clinical Trial Summary

The transparent cap-assisted endoscope has the function of fixing field of view and increasing visual space. It has been widely used in gastrointestinal examination and treatment. In this study, the investigators intend to apply transparent cap-assisted choledochoscopy to endoscopic biliary tract exploration and biopsy to investigate whether transparent cap-assisted choledochoscopy can improve operability, visual field clarity, and biopsy accuracy.

Clinical Trial Description

Recently, endoscopy has become more widely used in clinical practice. A straightforward method of improving mucosal visualization involves attachment of a transparent cap to the end of the endoscope. It has been widely used in gastrointestinal examination and treatment.This is a before-after study. In patients with suspected bile duct stricture, tandem ERCP combined with SpyGlass choledochoscopy procedures were carried out on the same day in random order, first without a transparent cap and then with a cap (without-to-with), or first with a cap and then without a cap (with-to-without). The differences in maneuverability, visual field clarity and biopsy accuracy of choledochoscopy with and without transparent cap were recorded to explore the application prospect of transparent cap assisted choledochoscopy. ;

Study Design

Related Conditions & MeSH terms

Bile Duct Stricture
Biliary Disease
Biliary Tract Neoplasms
Constriction, Pathologic
Endoscopic Retrograde Cholangiopancreatography
Gallbladder Diseases

Clinical Trial Details

NCT number	NCT05320497
Study type	Interventional
Source	Affiliated Hospital to Academy of Military Medical Sciences
Contact	Yan Liu, MD
Phone	13911798288
Email	13911798288@163.com
Status	Recruiting
Phase	N/A
Start date	April 14, 2022
Completion date	July 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01950572` - Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Completed	`NCT03101566` - Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer	Phase 2
Recruiting	`NCT05237193` - A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up
Not yet recruiting	`NCT06037655` - Chemotherapy Combined With Adebrelimab and Mecapegfilgrastim in Neoadjuvant Treatment of Potentially Resectable BTC	Phase 2
Recruiting	`NCT04584008` - Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics	N/A
Completed	`NCT00196105` - Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)	N/A
Completed	`NCT02558959` - Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer	Phase 2
Completed	`NCT02829918` - Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers	Phase 2
Completed	`NCT02784353` - Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy	N/A
Recruiting	`NCT05429203` - Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope	N/A
Recruiting	`NCT02255669` - Fully Covered SEMS Versus Partially Covered SEMS With Anti-migration System for Malignant Distal Biliary Obstruction	N/A
Completed	`NCT01731821` - Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy	Phase 3
Completed	`NCT00422409` - Endoscopic Stenting of Gastrointestinal Cancer	N/A
Terminated	`NCT02900248` - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Recruiting	`NCT03063554` - EUS BD vs ERCP TP for Pancreatic Cancer	N/A
Terminated	`NCT02615210` - Mid-Atlantic Research Group Single-Operator Cholangioscopic Assessment of Biliary Strictures	N/A
Completed	`NCT04595058` - LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent	N/A
Recruiting	`NCT04856761` - A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection
Recruiting	`NCT03427242` - Apatinib for Advanced Biliary Carcinoma	Phase 2
Terminated	`NCT00359320` - A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy	N/A